SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-069938
Filing Date
2021-05-20
Accepted
2021-05-20 16:35:39
Documents
1
Period of Report
2021-05-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2117144-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2117144-4_4seq1.xml 4 4141
  Complete submission text file 0001104659-21-069938.txt   5668
Mailing Address C/O STEMLINE THERAPEUTICS, INC. 750 LEXINGTON AVENUE, 6TH FLOOR NEW YORK NY 10022
Business Address
Cavan John T (Reporting) CIK: 0001503738 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36856 | Film No.: 21944971

Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Issuer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations